- About
- Advertise
- CureToday.com
- OncLive.com
- OncNursingNews.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2023 MJH Life Sciences™ and Cancer Network. All rights reserved.
Lilian Gien, MD | Authors
Lilian Gien, MD, Talks Next Steps for Immunotherapy Research in Recurrent Clear Cell Carcinoma of the Ovary
October 17, 2022
Lillian Gien, MD, spoke about continued use of immunotherapy in patients with recurrent clear cell carcinoma of the ovary following results of a trial examining pembrolizumab plus epacadostat.
Lilian Gien, MD, Reviews Pembrolizumab Plus Epacadostat in Recurrent Clear Cell Carcinoma of the Ovary
October 09, 2022
At 2022 IGCS, Lilian Gien, MD, spoke about a phase 2 trial which analyzed pembrolizumab plus epacadostat in patients with recurrent clear cell carcinoma of the ovary.
Advertisement
Advertisement